The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBreedon Regulatory News (BREE)

Share Price Information for Breedon (BREE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 364.50
Bid: 0.00
Ask: 450.00
Change: 0.00 (0.00%)
Spread: 85.50 (23.457%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 364.50
BREE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AGM Statement

30 Apr 2019 07:00

RNS Number : 4708X
Breedon Group PLC
30 April 2019
 

 

 

News release

30 April 2019

Breedon Group plc

AGM Statement

 

Breedon Group plc, the leading construction materials group in Great Britain and Ireland, issues the following update in advance of its Annual General Meeting at 2.00pm today:

 

"Trading in the first three months of this year was encouraging, with good progress made across the business, and the integration of Lagan continues to proceed as expected.

 

"Group revenues grew by 50 per cent to approximately £211 million compared with the first quarter of 2018 and on a like-for-like basis* were ahead 10 per cent, having benefited from much milder weather conditions this year.

 

"The underlying outlook remains positive for our markets. Construction output is forecast to grow by nearly three per cent in Great Britain and at an appreciably stronger rate in the Republic of Ireland over the next three years, led by infrastructure, industrial and housing development.

 

"We continue to commit substantial investment across our business, focused on delivering operational improvements, increasing capacity, broadening our geographical coverage and extending our mineral reserves and resources. In conjunction, our strong cash generation will ensure the continuing reduction of the Group's net debt.**

 

"We look forward to reporting our half-year results on 25 July. In the meantime, based on our performance in the year to date the Board's expectations for the full year remain unchanged."

* Like-for-like Group revenues exclude the impact of acquisitions and disposals.

** Net debt excludes the impact of adoption of IFRS 16.

 

- ends -

 

Note to editors

 

Breedon Group plc is a leading construction materials group in Great Britain and Ireland. It operates two cement plants and an extensive network of quarries, asphalt plants and ready-mixed concrete plants, together with slate production, concrete and clay products manufacturing, contract surfacing and highway maintenance operations. The Group employs nearly 3,000 people and has nearly 900 million tonnes of mineral reserves and resources. Its strategy is to continue growing organically and through the acquisition of businesses in the heavyside construction materials market.

For further information:

 

Breedon Group plc

Pat Ward, Group Chief Executive

Rob Wood, Group Finance Director

01332 694010

 

Stephen Jacobs, Head of Communications

07831 764592

 

Cenkos Securities (NOMAD and Joint Broker)

Max Hartley, 020 7397 8900

 

Numis (Joint Broker)

Ben Stoop/Heraclis Economides, 020 7260 1000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGMILMRTMBATBJL
Date   Source Headline
24th Apr 20244:40 pmRNSResult of AGM
24th Apr 20243:33 pmRNSDirector/PDMR Shareholding
24th Apr 20247:00 amRNSAGM Trading Update
5th Apr 20243:49 pmRNSDirector/PDMR Shareholding
4th Apr 20242:35 pmRNSDirector/PDMR Shareholding
28th Mar 20244:11 pmRNSTotal Voting Rights
18th Mar 202410:00 amRNS2023 Annual Report and Notice of AGM
12th Mar 20243:09 pmRNSApplication for Admission of Consideration Shares
7th Mar 20247:00 amRNSCompletion of Acquisition
6th Mar 20247:00 amRNSAcquisition
6th Mar 20247:00 amRNSFinal Results
29th Feb 20247:00 amRNSTotal Voting Rights
8th Feb 20243:51 pmRNSHolding(s) in Company
5th Feb 202410:00 amRNSNotice of Results
31st Jan 20249:18 amRNSTotal Voting Rights
29th Jan 20244:09 pmRNSHolding(s) in Company
29th Dec 20237:00 amRNSBlock listing six monthly return
29th Dec 20237:00 amRNSTotal Voting Rights
30th Nov 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSNovember Trading Statement
16th Nov 202310:07 amRNSDirector/PDMR Shareholding
8th Nov 20234:01 pmRNSDirector/PDMR Shareholding
31st Oct 20237:00 amRNSTotal Voting Rights
19th Oct 20231:59 pmRNSHolding(s) in Company
9th Oct 20232:24 pmRNSHolding(s) in Company
9th Oct 20232:23 pmRNSDirector/PDMR Shareholding
9th Oct 202311:46 amRNSDirector/PDMR Shareholding
9th Oct 202310:53 amRNSDirector/PDMR Shareholding
9th Oct 202310:47 amRNSHolding(s) in Company
6th Oct 20235:15 pmRNSDirector/PDMR Shareholding
5th Oct 20235:32 pmRNSHolding(s) in Company
3rd Oct 20235:30 pmRNSIntention to acquire additional shares of Breedon
3rd Oct 20237:00 amRNSInvestor site visit
2nd Oct 202311:18 amRNSInterim Dividend Timetable
29th Sep 20239:37 amRNSTotal Voting Rights
31st Aug 202310:15 amRNSTotal Voting Rights
30th Aug 20235:02 pmRNSDirector/PDMR Shareholding
31st Jul 202311:36 amRNSTotal Voting Rights
26th Jul 20237:00 amRNSInterim results 2023
3rd Jul 20231:55 pmRNSNotice of Interim Results 2023
30th Jun 20239:55 amRNSTotal Voting Rights
27th Jun 202311:48 amRNSBlock Listing of Ordinary Shares
13th Jun 202310:51 amRNSReduction of Capital Effective
6th Jun 20235:02 pmRNSOutcome of Court Hearing on Reduction of Capital
2nd Jun 20233:25 pmRNSHolding(s) in Company
1st Jun 202310:37 amRNSHolding(s) in Company
31st May 202312:35 pmRNSTotal Voting Rights
31st May 202311:30 amRNSHolding(s) in Company
24th May 202312:35 pmRNSDirector/PDMR Shareholding
23rd May 20235:31 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.